166 related articles for article (PubMed ID: 15114687)
1. [Chemical evaluation by cancer cell line panel and its role in molecular target-based anticancer drug screening].
Yamori T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):485-90. PubMed ID: 15114687
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of action mechanisms of toxic chemicals using JFCR39, a panel of human cancer cell lines.
Nakatsu N; Nakamura T; Yamazaki K; Sadahiro S; Makuuchi H; Kanno J; Yamori T
Mol Pharmacol; 2007 Nov; 72(5):1171-80. PubMed ID: 17702889
[TBL] [Abstract][Full Text] [Related]
3. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.
Yamori T
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S74-9. PubMed ID: 12819939
[TBL] [Abstract][Full Text] [Related]
4. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Kong D; Yamori T
Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
[TBL] [Abstract][Full Text] [Related]
5. [A human cell line panel for screening anti-cancer drugs].
Yamori T
Gan To Kagaku Ryoho; 1997 Jan; 24(2):129-35. PubMed ID: 9030223
[TBL] [Abstract][Full Text] [Related]
6. One pot synthesis of thiazolodihydropyrimidinones and evaluation of their anticancer activity.
Holla BS; Rao BS; Sarojini BK; Akberali PM
Eur J Med Chem; 2004 Sep; 39(9):777-83. PubMed ID: 15337290
[TBL] [Abstract][Full Text] [Related]
7. NCI's anticancer drug screening program may not be selecting for clinically active compounds.
Brown JM
Oncol Res; 1997; 9(5):213-5. PubMed ID: 9306428
[TBL] [Abstract][Full Text] [Related]
8. Chemical data mining of the NCI human tumor cell line database.
Wang H; Klinginsmith J; Dong X; Lee AC; Guha R; Wu Y; Crippen GM; Wild DJ
J Chem Inf Model; 2007; 47(6):2063-76. PubMed ID: 17915856
[TBL] [Abstract][Full Text] [Related]
9. [Sensitivity profile of a panel of cell lines designed for the evaluation of in vitro cytotoxicity].
León CJ; Gómez SM; Morantes SJ; Cordero CP; Aristizábal FA
Biomedica; 2006 Mar; 26(1):161-8. PubMed ID: 16929914
[TBL] [Abstract][Full Text] [Related]
10. Semisynthesis and in vitro anticancer activities of andrographolide analogues.
Jada SR; Subur GS; Matthews C; Hamzah AS; Lajis NH; Saad MS; Stevens MF; Stanslas J
Phytochemistry; 2007 Mar; 68(6):904-12. PubMed ID: 17234223
[TBL] [Abstract][Full Text] [Related]
11. 50 years of preclinical anticancer drug screening: empirical to target-driven approaches.
Suggitt M; Bibby MC
Clin Cancer Res; 2005 Feb; 11(3):971-81. PubMed ID: 15709162
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
13. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
14. Chemical approaches to the discovery and development of cancer therapies.
Neidle S; Thurston DE
Nat Rev Cancer; 2005 Apr; 5(4):285-96. PubMed ID: 15803155
[TBL] [Abstract][Full Text] [Related]
15. Web-based tools for mining the NCI databases for anticancer drug discovery.
Fang X; Shao L; Zhang H; Wang S
J Chem Inf Comput Sci; 2004; 44(1):249-57. PubMed ID: 14741034
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
Zarranz B; Jaso A; Aldana I; Monge A
Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of alcyopterosin A and illudalane derivatives as anticancer agents.
Finkielsztein LM; Bruno AM; Renou SG; Moltrasio Iglesias GY
Bioorg Med Chem; 2006 Mar; 14(6):1863-70. PubMed ID: 16321541
[TBL] [Abstract][Full Text] [Related]
18. New screening system for selection of anticancer drugs for treatment of human colorectal cancer.
Scheithauer W; Clark GM; Moyer MP; Von Hoff DD
Cancer Res; 1986 Jun; 46(6):2703-8. PubMed ID: 3698003
[TBL] [Abstract][Full Text] [Related]
19. Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines.
Stoeger SM; Cowan KH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):807-18. PubMed ID: 18661133
[TBL] [Abstract][Full Text] [Related]
20. Update on NCI in vitro drug screen utilities.
Holbeck SL
Eur J Cancer; 2004 Apr; 40(6):785-93. PubMed ID: 15120034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
